Novartis Investigative Site

Turin, Piedmont 10128

0 studies enrolling now · 4 studies all time

What they study most

Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic, Neoplasms, Breast, Ovarian Cancer

Studies at this site

• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early
• Ofatumumab Plus Bendamustine in Frontline and Relapsed Chronic Lymphocytic Leukaemia (CLL) — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING